{"id":69,"date":"2023-06-22T15:41:33","date_gmt":"2023-06-22T15:41:33","guid":{"rendered":"https:\/\/accord-prostata.se\/hcp\/?page_id=69"},"modified":"2025-02-27T09:14:08","modified_gmt":"2025-02-27T09:14:08","slug":"utbildning-och-material","status":"publish","type":"page","link":"https:\/\/accord-prostata.se\/hcp\/utbildning-och-material\/","title":{"rendered":"Resources"},"content":{"rendered":"\n
<\/div>\n
\n
\n

Utbildning och material<\/strong><\/h1>\n\n\n\n


F\u00e5 tillg\u00e5ng till och ladda ner information som \u00e4r utformade f\u00f6r att st\u00f6dja dig och dina patienter.<\/p>\n<\/div>\n\n\n\n

\n\n
\n \"Glasses\"\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n

Information f\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal<\/h2>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n\n
\n \"\"\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer \u2013 Shore, et al. 20201<\/sup><\/strong><\/h3>\n\n\n\n

HERO-studien var en multinationell, randomiserad, \u00f6ppen fas 3-studie f\u00f6r att utv\u00e4rdera effekt och s\u00e4kerhet av ORGOVYX\u00ae, j\u00e4mf\u00f6rt med leuprorelin, hos m\u00e4n med avancerad prostatacancer.1<\/sup><\/p>\n\n\n\n

\n \n <\/svg><\/span> L\u00e4s mer (NEJM)<\/span>\n <\/a>\n <\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n
\n
\n \"\" <\/div>\n
\n

ESMO eUpdate \u2013 Rekommendationer f\u00f6r behandling av prostatacancer<\/h2>\n

European Society for Medical Oncologys (ESMO) riktlinjer f\u00f6r klinisk praxis f\u00f6r prostatacancer ger information om den nuvarande behandlingen av prostatacancer.2<\/sup><\/p>\n <\/div>\n

\n
\n \n <\/svg><\/span> L\u00e4s mer (ESMO)<\/span>\n \n <\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n \"\" <\/div>\n
\n

ESMO-MCBS po\u00e4ng – Relugolix<\/h2>\n

ORGOVYX\u00ae<\/sup> (relugolix) erh\u00f6ll en ESMO-MCBS-po\u00e4ng (European Society for Medical Oncology-Magnitude of Clinical Benefit Scale) p\u00e5 4 av 5 f\u00f6r en icke-botande behandling.3<\/sup><\/p>\n <\/div>\n

\n
\n \n <\/svg><\/span> Till ESMO<\/span>\n \n <\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n \"\" <\/div>\n
\n

ORGOVYX\u00ae<\/sup> (relugolix) SPC<\/h2>\n

Senaste versionen av produktresum\u00e9n (SPC). <\/p>\n <\/div>\n

\n
\n \n <\/svg><\/span> Till produktresum\u00e9n<\/span>\n \n <\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n
\n \"\" <\/div>\n
\n

EAUs behandlingsriktlinjer f\u00f6r prostatacancer<\/h2>\n

Europeiska urologf\u00f6reningens behandlingsriktlinjer har information om behandling av olika stadier av prostatacancer.4<\/p>\n <\/div>\n

\n
\n \n <\/svg><\/span> L\u00e4s mer (EAU)<\/span>\n \n <\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n \"\" <\/div>\n
\n

NCCN behandlingsriktlinjer<\/h2>\n

The National Comprehensive Cancer Network (NCCN) har publicerat uppdaterade kliniska behandlingsriktlinjer f\u00f6r prostatacancer.5<\/p>\n <\/div>\n

\n
\n \n <\/svg><\/span> L\u00e4s mer (NCCN)<\/span>\n \n <\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n

Om du vill ha mer information om ORGOVYX\u00ae<\/sup>, v\u00e4nligen kontakta din lokala Accord-representant.<\/h3>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
Referenser<\/strong><\/h5>\n\n\n\n
    \n
  1. Shore ND, et al. N Engl J Med.<\/em> 2020;382(4):2187\u20132196.<\/li>\n\n\n\n
  2. ESMO eUpdate \u2013 Rekommendationer f\u00f6r behandling av prostatacancer. Available from: https:\/\/www.esmo.org\/guidelines\/guidelines-by-topic\/genitourinary-cancers\/prostate-cancer\/eupdate-prostate-cancer-treatment-recommendations<\/a> (\u00c5tkomst december 2024).<\/li>\n\n\n\n
  3. Europeiska s\u00e4llskapet f\u00f6r medicinsk onkologi. Relugolix. Tillg\u00e4nglig p\u00e5: https:\/\/www.esmo.org\/guidelines\/esmo-mcbs\/esmo-mcbs-for-solid-tumours\/esmo-mcbs-scorecards\/scorecard-321-1<\/a> (\u00c5tkomst december 2024).<\/li>\n\n\n\n
  4. European Association of Urology. Prostate Cancer. Available at: https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/quality-of-life-outcomes-in-prostate-cancer <\/a>(\u00c5tkomst december 2024).<\/li>\n\n\n\n
  5. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae<\/sup>) Prostate Cancer 2024. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf<\/a> (\u00c5tkomst december 2024).<\/li>\n<\/ol>\n<\/div>\n\n\n\n
    \n
    Akronymer<\/strong><\/h5>\n\n\n\n

    EAU<\/strong>, European Association of Urology.
    ESMO-MCBS<\/strong>, European Society for Medical Oncology-Magnitude of Clinical Benefits Scale.
    NCCN<\/strong>, National Comprehensive Cancer Network.
    SPC<\/strong>, produktresum\u00e9.<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

    \n
    \n
    \n
    \n
    \n

    \u25bc<\/span> Detta l\u00e4kemedel \u00e4r f\u00f6rem\u00e5l f\u00f6r ut\u00f6kad \u00f6vervakning. F\u00f6r fullst\u00e4ndig SPC Orgovyx klicka h\u00e4r<\/a>.<\/p>\n <\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

    \n
    \n

    SE-Onc-Org-01460 | Senast uppdaterad december 2024<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-69","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nInformation | ORGOVYX\u00ae | F\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal<\/title>\n<meta name=\"description\" content=\"Denna webbsida \u00e4r endast avsedd f\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal bosatt i Sverige.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Information | ORGOVYX\u00ae | F\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal\" \/>\n<meta property=\"og:description\" content=\"Denna webbsida \u00e4r endast avsedd f\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal bosatt i Sverige.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/accord-prostata.se\/hcp\/utbildning-och-material\/\" \/>\n<meta property=\"og:site_name\" content=\"Orgovyx HCP\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-27T09:14:08+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/accord-prostata.se\\\/hcp\\\/utbildning-och-material\\\/\",\"url\":\"https:\\\/\\\/accord-prostata.se\\\/hcp\\\/utbildning-och-material\\\/\",\"name\":\"Information | ORGOVYX\u00ae | F\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/accord-prostata.se\\\/hcp\\\/#website\"},\"datePublished\":\"2023-06-22T15:41:33+00:00\",\"dateModified\":\"2025-02-27T09:14:08+00:00\",\"description\":\"Denna webbsida \u00e4r endast avsedd f\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal bosatt i Sverige.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/accord-prostata.se\\\/hcp\\\/utbildning-och-material\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/accord-prostata.se\\\/hcp\\\/utbildning-och-material\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/accord-prostata.se\\\/hcp\\\/utbildning-och-material\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/accord-prostata.se\\\/hcp\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Resources\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/accord-prostata.se\\\/hcp\\\/#website\",\"url\":\"https:\\\/\\\/accord-prostata.se\\\/hcp\\\/\",\"name\":\"Orgovyx HCP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/accord-prostata.se\\\/hcp\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Information | ORGOVYX\u00ae | F\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal","description":"Denna webbsida \u00e4r endast avsedd f\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal bosatt i Sverige.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_GB","og_type":"article","og_title":"Information | ORGOVYX\u00ae | F\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal","og_description":"Denna webbsida \u00e4r endast avsedd f\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal bosatt i Sverige.","og_url":"https:\/\/accord-prostata.se\/hcp\/utbildning-och-material\/","og_site_name":"Orgovyx HCP","article_modified_time":"2025-02-27T09:14:08+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/accord-prostata.se\/hcp\/utbildning-och-material\/","url":"https:\/\/accord-prostata.se\/hcp\/utbildning-och-material\/","name":"Information | ORGOVYX\u00ae | F\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal","isPartOf":{"@id":"https:\/\/accord-prostata.se\/hcp\/#website"},"datePublished":"2023-06-22T15:41:33+00:00","dateModified":"2025-02-27T09:14:08+00:00","description":"Denna webbsida \u00e4r endast avsedd f\u00f6r h\u00e4lso- och sjukv\u00e5rdspersonal bosatt i Sverige.","breadcrumb":{"@id":"https:\/\/accord-prostata.se\/hcp\/utbildning-och-material\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/accord-prostata.se\/hcp\/utbildning-och-material\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/accord-prostata.se\/hcp\/utbildning-och-material\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/accord-prostata.se\/hcp\/"},{"@type":"ListItem","position":2,"name":"Resources"}]},{"@type":"WebSite","@id":"https:\/\/accord-prostata.se\/hcp\/#website","url":"https:\/\/accord-prostata.se\/hcp\/","name":"Orgovyx HCP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/accord-prostata.se\/hcp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/accord-prostata.se\/hcp\/wp-json\/wp\/v2\/pages\/69","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/accord-prostata.se\/hcp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/accord-prostata.se\/hcp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/accord-prostata.se\/hcp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/accord-prostata.se\/hcp\/wp-json\/wp\/v2\/comments?post=69"}],"version-history":[{"count":135,"href":"https:\/\/accord-prostata.se\/hcp\/wp-json\/wp\/v2\/pages\/69\/revisions"}],"predecessor-version":[{"id":2211,"href":"https:\/\/accord-prostata.se\/hcp\/wp-json\/wp\/v2\/pages\/69\/revisions\/2211"}],"wp:attachment":[{"href":"https:\/\/accord-prostata.se\/hcp\/wp-json\/wp\/v2\/media?parent=69"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}